Thermo Fisher Scientific Return on Equity (ROE) Growth & History (TMO)
Thermo Fisher Scientific's return on equity was 13.02% for fiscal 2025.
View full Thermo Fisher Scientific company overviewThermo Fisher Scientific annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 13.02% | −0.14 pp |
| 2024 | 2024-12-31 | 13.15% | −0.06 pp |
| 2023 | 2023-12-31 | 13.22% | −3.20 pp |
| 2022 | 2022-12-31 | 16.42% | −4.11 pp |
| 2021 | 2021-12-31 | 20.53% | +0.65 pp |
| 2020 | 2020-12-31 | 19.87% | +6.96 pp |
| 2019 | 2019-12-31 | 12.92% | — |
| 2013 | 2013-12-31 | 7.88% | +0.16 pp |
| 2012 | 2012-12-31 | 7.72% | −1.03 pp |
| 2011 | 2011-12-31 | 8.75% | +2.02 pp |
| 2010 | 2010-12-31 | 6.73% | +1.12 pp |
| 2009 | 2009-12-31 | 5.60% | −1.07 pp |
| 2008 | 2008-12-31 | 6.68% | — |
Thermo Fisher Scientific quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-27 | 3.32% | +0.08 pp |
| Q1 2026 | 2026-03-28 | 3.13% | +0.09 pp |
| Q4 2025 | 2025-12-31 | 3.76% | +0.06 pp |
| Q3 2025 | 2025-09-27 | 3.18% | −0.20 pp |
| Q2 2025 | 2025-06-28 | 3.24% | −0.09 pp |
| Q1 2025 | 2025-03-29 | 3.05% | +0.16 pp |
| Q4 2024 | 2024-12-31 | 3.70% | +0.13 pp |
| Q3 2024 | 2024-09-28 | 3.38% | −0.42 pp |
| Q2 2024 | 2024-06-29 | 3.33% | +0.16 pp |
| Q1 2024 | 2024-03-30 | 2.89% | −0.11 pp |
| Q4 2023 | 2023-12-31 | 3.58% | −0.02 pp |
| Q3 2023 | 2023-09-30 | 3.81% | +0.32 pp |
| Q2 2023 | 2023-07-01 | 3.17% | −0.84 pp |
| Q1 2023 | 2023-04-01 | 3.00% | −2.43 pp |
| Q4 2022 | 2022-12-31 | 3.60% | −0.58 pp |
| Q3 2022 | 2022-10-01 | 3.49% | −1.55 pp |
| Q2 2022 | 2022-07-02 | 4.01% | −1.08 pp |
| Q1 2022 | 2022-04-02 | 5.43% | −1.29 pp |
| Q4 2021 | 2021-12-31 | 4.17% | — |
| Q3 2021 | 2021-10-02 | 5.04% | — |
| Q2 2021 | 2021-07-03 | 5.09% | — |
| Q1 2021 | 2021-04-03 | 6.72% | — |
| Q1 2014 | 2014-03-29 | 2.91% | +0.75 pp |
| Q4 2013 | 2013-12-31 | 2.06% | −0.39 pp |
| Q3 2013 | 2013-09-28 | 1.97% | +0.06 pp |
| Q2 2013 | 2013-06-29 | 1.77% | +0.23 pp |
| Q1 2013 | 2013-03-30 | 2.16% | +0.34 pp |
| Q4 2012 | 2012-12-31 | 2.45% | +0.54 pp |
| Q3 2012 | 2012-09-29 | 1.91% | +0.19 pp |
| Q2 2012 | 2012-06-30 | 1.54% | −1.85 pp |
| Q1 2012 | 2012-03-31 | 1.83% | +0.18 pp |
| Q4 2011 | 2011-12-31 | 1.91% | −0.02 pp |
| Q3 2011 | 2011-10-01 | 1.72% | −0.03 pp |
| Q2 2011 | 2011-07-02 | 3.39% | +1.85 pp |
| Q1 2011 | 2011-04-02 | 1.65% | +0.14 pp |
| Q4 2010 | 2010-12-31 | 1.93% | +0.16 pp |
| Q3 2010 | 2010-10-02 | 1.75% | +0.30 pp |
| Q2 2010 | 2010-07-03 | 1.54% | +0.16 pp |
| Q1 2010 | 2010-04-03 | 1.50% | — |
| Q4 2009 | 2009-12-31 | 1.77% | — |
| Q3 2009 | 2009-09-26 | 1.45% | — |
| Q2 2009 | 2009-06-27 | 1.38% | — |
Thermo Fisher Scientific return on equity trends
Over the last five fiscal years, Thermo Fisher Scientific's return on equity decreased from 19.87% to 13.02%, a change of −6.85 percentage points. The latest reported quarter, Q2 2026, shows 3.32%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Thermo Fisher Scientific source filings ↗